Abstract
Background: Current dialysis devices are not able to react when unexpected changes occur during dialysis treatment or to learn about experience for therapy personalization. Furthermore, great efforts are dedicated to develop miniaturized artificial kidneys to achieve a continuous and personalized dialysis therapy, in order to improve the patient’s quality of life. These innovative dialysis devices will require a real-time monitoring of equipment alarms, dialysis parameters, and patient-related data to ensure patient safety and to allow instantaneous changes of the dialysis prescription for the assessment of their adequacy. The analysis and evaluation of the resulting large-scale data sets enters the realm of “big data” and will require real-time predictive models. These may come from the fields of machine learning and computational intelligence, both included in artificial intelligence, a branch of engineering involved with the creation of devices that simulate intelligent behavior. The incorporation of artificial intelligence should provide a fully new approach to data analysis, enabling future advances in personalized dialysis therapies. With the purpose to learn about the present and potential future impact on medicine from experts in artificial intelligence and machine learning, a scientific meeting was organized in the Hospital Universitari Bellvitge (L’Hospitalet, Barcelona). As an outcome of that meeting, the aim of this review is to investigate artificial intel ligence experiences on dialysis, with a focus on potential barriers, challenges, and prospects for future applications of these technologies. Summary and Key Messages: Artificial intelligence research on dialysis is still in an early stage, and the main challenge relies on interpretability and/or comprehensibility of data models when applied to decision making. Artificial neural networks and medical decision support systems have been used to make predictions about anemia, total body water, or intradialysis hypotension and are promising approaches for the prescription and monitoring of hemodialysis therapy. Current dialysis machines are continuously improving due to innovative technological developments, but patient safety is still a key challenge. Real-time monitoring systems, coupled with automatic instantaneous biofeedback, will allow changing dialysis prescriptions continuously. The integration of vital sign monitoring with dialysis parameters will produce large data sets that will require the use of data analysis techniques, possibly from the area of machine learning, in order to make better decisions and increase the safety of patients.
References
1.
Saran R, Robinson B, Abbott KC, Agodoa LYC, Ayanian J, Bragg-Gresham J, et al: US renal data system 2016 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis 2017; 69:A7–A8.
2.
Ficheux A, Gayrard N, Duranton F, Guzman C, Szwarc I, Vetromile F, Brunet P, Servel MF, Argilés A: A reliable method to assess the water permeability of a dialysis system: the global ultrafiltration coefficient. Nephrol Dial Transplant 2017; 32: 364–370.
3.
Ronco C, Ghezzi PM, La Greca G: The role of technology in hemodialysis. J Nephrol 1999; 12(suppl 2):S68–S81.
4.
Locatelli F, Buoncristiani U, Canaud B, Köhler H, Petitclerc T, Zuchelli P: Hemodyalisis with on-line monitoring equipment: tools or toys? Nephrol Dial Transplant 2005; 20: 22–33.
5.
Senders JT, Arnaout O, Karhade AV, Desenbrock HH, Gormley WB, Broekman ML, Smith TR: Natural and artificial intelligence in neurosurgery: a systematic review. Neurosurgery 2017, Epub ahead of print.
6.
Feng R, Badgeley M, Mocco J, Oermann EK: Deep learning guided stroke management: a review of clinical applications. J Neurointerv Surg 2017, Epub ahead of print.
7.
Leonelli S: Data-Centric Biology: A Philosophical Study. Chicago, University of Chicago Press, 2016.
8.
Reza SM: Transforming big data into computational models for personalized medicine and health care. Dialogues Clin Neurosci 2016; 18: 339–343.
9.
Safdar S, Zafar S, Zafar N, Khan NF: Machine learning based decision support systems (DSS) for heart disease diagnosis: a review. Artif Intell Rev 2018, in press, available online: .
10.
Pombo N, Araújo P, Viana J: Knowledge discovery in clinical decision support systems for pain management: a systematic review. Artif Intell Med 2014; 60: 1–11.
11.
Vellido A, Ribas V, Morales C, Ruiz-Santamaría A, Ruiz-Rodríguez J: Machine learning for critical care: state-of-the-art and a sepsis case study. Biomed Eng Online, in press.
12.
Cabitza F, Rasoini R, Gensini GF: Unintended consequences of machine learning in medicine. JAMA 2017; 318: 517–518.
13.
Goodman B, Flaxman S: European Union regulations on algorithmic decision making and a “right to explanation.” AI Magazine 2017; 38: 50–57.
14.
Vellido A, Martín-Guerrero JD, Lisboa PJG: Making machine learning models interpretable; in Verleysen M (ed): Proceedings of the 20th European Symposium on Artificial Neural Networks, Computational Intelligence and Machine Learning (ESANN 2012). Bruges, 2012, pp 163–172.
15.
Jackups R: Deep learning makes its way to the clinical laboratory. Clin Chem 2017; 63: 1790–1791.
16.
Tu JV: Advantages and disadvantages of using artificial neural networks versus logistic regression for predicting medical outcomes. J Clin Epidemiol 1996; 49: 1225–1231.
17.
Reid MJ: Black-box machine learning: implications for healthcare. Polygeia, 2017. https://www.polygeia.com/single-post/2017/04/06/Black-box-machine-learning-implications-for-healthcare.
18.
Dominik S, Sedlmair M, Zhang L, Lee JA, Peltonen J, Weiskopf D, North SC, Keim DA: What you see is what you can change: human-centered machine learning by interactive visualization. Neurocomputing 2017; 268: 164–175.
19.
Bhanot G, Biehl M, Villmann T, Zühlke D: Biomedical data analysis in translational research: integration of expert knowledge and interpretable models; in Verleysen M (ed), 25th European Symposium on Artificial Neural Networks, Computational Intelligence and Machine Learning (ESANN 2017). Bruges, 2017, pp 177–186.
20.
Brier ME, Gaweda AE: Artificial intelligence for optimal anemia management in end-stage renal disease. Kidney Int 2016; 90: 259–261.
21.
Fernández EA, Valtuille R, Balzarini M: Artificial neural networks applications in dialysis; in Azar A (ed): Modeling and Control of Dialysis Systems. Studies in Computational Intelligence. Berlin, Springer, 2013, vol 405, pp 1145–1179.
22.
Chiu JS, Chong CF, Lin YF, Wu CC, Wang YF, Li YC: Applying an artificial neural network to predict total body water in hemodialysis patients. Am J Nephrol 2005; 25: 507–513.
23.
Wang YF, Hu TM, Wu CC, Yu FC, Fu CM, Lin SH, Huang WH, Chiu JS: Prediction of target range of intact parathyroid hormone in hemodialysis patients with artificial neural network. Comput Methods Programs Biomed 2006; 83: 111–119.
24.
Martin-Guerrero JD, Gómez F, Soria-Olivas E, Schmidhuber J, Climente-Marti M, Jiménez-Torres NV: A reinforcement learning approach for individualizing erythropoietin dosages in hemodialysis patients. Expert Syst Appl 2009; 36: 9737–9742.
25.
Barbieri C, Molina M, Ponce P, Tothova M, Cattinelli I, Titapiccolo JI, Mari F, Amato C, Leipold F, Wehmeyer W, Stuard S: An international observational study suggests that artificial intelligence for clinical decision support optimizes anemia management in hemodialysis patients. Kidney Int 2016; 90: 422–429.
26.
Rodrigues M, Peixoto H, Esteves M, Machado J: Understanding stroke in dialysis and chronic kidney disease. Proc Comput Sci 2017; 113: 591–596.
27.
Saadat S, Aziz A, Ahmad H, Imtiaz H, Zara SS, Kazmi A, Aslam S, Naqvi N, Saadat S: Predicting quality of life changes in hemodialysis patients using machine learning: generation of an early warning system. Cureus 2017; 9:e1713.
28.
Bobrowski L, Łukaszuk T, Lindholm B, Stenvinkel P, Heimburger O, Axelsson J, Bárány P, Carrero JJ, Qureshi AR, Luttropp K, Debowska M, Nordfors L, Schalling M, Waniewski J: Selection of genetic and phenotypic features associated with inflammatory status of patients on dialysis using relaxed linear separability method. PLoS One 2014; 9:e86630.
29.
Ricci Z, Romagnoli S, Ronco C: Automatic dialysis and continuous renal replacement therapy: keeping the primacy of human consciousness and fighting the dark side of technology. Blood Purif 2017; 44: 271–275.
30.
Lankhorst CE, Wish JB: Anemia in renal disease: diagnosis and management. Blood Rev 2010; 24: 39–47.
31.
Foley RN: Treatment of anemia in chronic kidney disease: known, unknown, and both. J Blood Med 2011; 2: 103–112.
32.
Martínez-Martínez JM, Escandell-Montero P, Barbieri C, Soria-Olivas E, Mari F, Martinez Sober M, Amato C, Serrano Lopez A, Bassi M, Magdalena Benedito R, Stopper A, Gatti E: Prediction of the hemoglobin level in hemodialysis patients using machine learning techniques. Comput Methods Programs Biomed 2014; 117: 208–217.
33.
Barbieri C, Mari F, Stopper A, Gatti E, Escandell-Montero P, Martínez-Martínez JM, Martín-Guerrero JD: A new machine learning approach for predicting the response to anemia treatment in a large cohort of end stage renal disease patients undergoing dialysis. Comput Biol Med 2015; 61: 56–61.
34.
Escandell-Montero P, Chermisi M, Martínez-Martínez JM, Gomez Sanchis J, Barbieri C, Soria Olivas E, Mari F, Vila Frances J, Stopper A, Gatti E, Martin Guerrero JD: Optimization of anemia treatment in hemodialysis patients via reinforcement learning. Artif Intell Med 2014; 62: 47–60.
35.
Stefánsson BV, Brunelli SM, Cabrera C, Rosenbaum D, Anum E, Ramakrishnam K, Jensen DE, Stalhammar NO: Intradialytic hypotension and risk of cardiovascular disease. Clin J Am Soc Nephrol 2014; 9: 2124–2132.
36.
Santoro A, Mancini E, Paolini F, Spongano M, Zucchelli P: Automatic control of blood volume trends during hemodialysis. ASAIO J 1994; 40:M419–M422.
37.
Leung KCW, Quinn RR, Ravani P, Duff H, MacRae JM: Randomized crossover trial of blood volume monitoring-guided ultrafiltration biofeedback to reduce intradialytic hypotensive episodes with hemodialysis. Clin J Am Soc Nephrol 2017; 12: 1831–1840.
38.
Nesrallah GE, Suri RS, Thiessen-Philbrook H, Heidenheim P, Lindsay RM: Can extracellular fluid volume expansion in hemodialysis patients be safely reduced using the hemocontrol biofeedback algorithm? A randomized trial. ASAIO J 2008; 54: 270–274.
39.
Selby NM, Lambie SH, Camici PG, Baker CS, McIntyre CW: Occurrence of regional ventricular dysfunction in patients undergoing standard and biofeedback dialysis. Am J Kidney Dis 2006; 47: 830–841.
40.
Winkler RE, Grandi F, Santoro A: Blood volume regulation; in Goretti Penido M (ed): Technical Problems in Patients on Hemodialysis. London, InTech, 2011, chapt 15.
41.
Ettema EM, Kuipers J, Groen H, Kema IP, Westerhuis R, de Jong PE, Franssen CFM: Vasopressin release is enhanced by the Hemocontrol biofeedback system and could contribute to better haemodynamic stability during haemodialysis. Nephrol Dial Transplant 2012; 27: 3263–3270.
42.
Doria M, Genovesi S, Biagi F, Steckiph D, Mancini E, Stella A, Santoro A: The dialysis staff workload and the blood volume tracking system during the hemodialysis sessions of hypotension-prone patients. Int J Artif Organs 2014; 37: 292–298.
43.
Tijink MS, Wester M, Glorieux G, Gerritsen KG, Sun J, Swart PC, Borneman Z, Wessling M, Vanholder R, Joles JA: Stamatialis: mixed matrix hollow fiber membranes for removal of protein-bound toxins from human plasma. Biomaterials 2013; 34: 7819–7828.
44.
Agar J: Review: understanding sorbent dialysis systems. Nephrology 2010; 15: 406–411.
45.
Armignacco P, Garzotto F, Neri M, Lorenzin A, Ronco C: WAK engineering evolution. Blood Purif 2015; 39: 1–3.
46.
Gura V, Macy AS, Beizai M, Ezon C, Golper TA: Technical breakthroughs in the wearable artificial kidney (WAK). Clin J Am Soc Nephrol 2009; 4: 1441–1448.
47.
Roy S, Goldman K, Marchant R, Zydney A, Brown D, Fleischman A, Conlisk A, Desai T, Duffy S, Humes H, Fissell W: Implanted renal replacement for end-stage renal disease. Panminerva Med 2011; 53: 155–166.
48.
Nadkarni GN, Coca SG, Wyatt CM: Big data in nephrology: promises and pitfalls. Kidney Int 2016; 90: 240–241.
49.
Ketchersid T: Big data in nephrology: friend or foe? Blood Purif 2013; 36: 160–164.
50.
Russell SJ, Norvig P: Artificial intelligence: a modern approach; in Russell SJ, Norvig P (eds): Prentice Hall Series in Artificial Intelligence, ed 3. London, Pearson Education, 2009.
51.
Goodfellow I, Bengio Y, Courville A: Deep Learning. Cambridge, MIT Press, 2016.
52.
Zeng T, Wu B, Ji S: DeepEM3D: approaching human-level performance on 3D anisotropic EM image segmentation. Bioinformatics 2017; 33: 2555–2562.
53.
Lake BM, Salakhutdinov R, Tenenbaum JB: Human-level concept learning through probabilistic program induction. Science 2015; 350: 1332–1338.
54.
Xiong W, Droppo J, Huang X, Seide F, Seltzer M, Stolcke A, Yu D, Zweig G: Achieving human parity in conversational speech recognition. arXiv 2016;arXiv:1610.05256v2.
55.
Yu KH, Zhang Ce, Berry GJ, Altman RB, Ré C, Rubin DL, Snyder M: Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image features. Nat Commun 2016; 7: 12474.
56.
Esteva A, Kuprel B, Novoa RA, Ko J, Swetter SM, Blau HM, Thrun S: Dermatologist-level classification of skin cancer with deep neural networks. Nature 2017; 542: 115–118.
57.
Weng SF, Reps J, Kai J, Garibaldi JM, Qureshi N: Can machine-learning improve cardiovascular risk prediction using routine clinical data? PLoS One 2017; 12: 0174944.
58.
How hospitals could be rebuilt, better than before. The Economist, April 2017. https://www.economist.com/news/international/21720278-technology-could-revolutionise-way-they-work-how-hospitals-could-be-rebuilt-better.
59.
Bonnefon JF, Shariff A, Rahwan I: The social dilemma of autonomous vehicles. Science 2016; 352: 1573–1576.
60.
Luetge C: The German ethics code for automated and connected driving. Philos Technol 2017; 30: 547–558.
61.
Carpenter J: Google’s algorithm shows prestigious job ads to men, but not to women. Washington Post, 2015. https://www.washingtonpost.com/news/the-intersect/wp/2015/07/06/googles-algorithm-shows-prestigious-job-ads-to-men-but-not-to-women-heres-why-that-should-worry-you.
62.
Smith J: Crime prediction tool may be reinforcing discriminatory policing. Business Insider, 2016. http://www.businessinsider.com/predictive-policing-discriminatory-police-crime-2016-10.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
